Short Interest in AirSculpt Technologies, Inc. (NASDAQ:AIRS) Declines By 28.9%

AirSculpt Technologies, Inc. (NASDAQ:AIRS) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 3,416,693 shares, a drop of 28.9% from the November 30th total of 4,804,380 shares. Currently, 23.4% of the company’s stock are short sold. Based on an average daily trading volume, of 683,627 shares, the short-interest ratio is currently 5.0 days. Based on an average daily trading volume, of 683,627 shares, the short-interest ratio is currently 5.0 days. Currently, 23.4% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Leerink Partners reaffirmed a “market perform” rating and set a $6.00 price objective on shares of AirSculpt Technologies in a report on Tuesday, November 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of AirSculpt Technologies in a research report on Monday. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $5.50.

AirSculpt Technologies Stock Performance

NASDAQ:AIRS opened at $1.97 on Wednesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.51 and a quick ratio of 0.51. The firm has a market cap of $123.01 million, a price-to-earnings ratio of -6.57 and a beta of 2.62. The firm’s fifty day moving average price is $5.15 and its 200 day moving average price is $6.02. AirSculpt Technologies has a 1-year low of $1.53 and a 1-year high of $12.00.

AirSculpt Technologies (NASDAQ:AIRS) last released its earnings results on Friday, November 7th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.03). The firm had revenue of $34.99 million during the quarter, compared to analyst estimates of $39.80 million. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%. On average, sell-side analysts expect that AirSculpt Technologies will post -0.01 EPS for the current year.

Institutional Trading of AirSculpt Technologies

Institutional investors have recently modified their holdings of the business. Vesey Street Capital Partners L.L.C. raised its position in AirSculpt Technologies by 3.4% in the second quarter. Vesey Street Capital Partners L.L.C. now owns 30,324,180 shares of the company’s stock worth $146,466,000 after acquiring an additional 1,000,000 shares in the last quarter. Balyasny Asset Management L.P. increased its holdings in shares of AirSculpt Technologies by 128.5% in the 2nd quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock valued at $5,380,000 after purchasing an additional 626,309 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of AirSculpt Technologies by 10.8% in the third quarter. Vanguard Group Inc. now owns 782,543 shares of the company’s stock valued at $6,276,000 after purchasing an additional 76,291 shares during the period. FourWorld Capital Management LLC grew its position in AirSculpt Technologies by 50.0% during the second quarter. FourWorld Capital Management LLC now owns 382,886 shares of the company’s stock worth $1,849,000 after buying an additional 127,676 shares during the period. Finally, CenterBook Partners LP increased its holdings in AirSculpt Technologies by 59.4% in the third quarter. CenterBook Partners LP now owns 355,081 shares of the company’s stock valued at $2,848,000 after buying an additional 132,327 shares in the last quarter. 91.54% of the stock is currently owned by hedge funds and other institutional investors.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.